SHELBY POTTER: Open Payments
NPI 1366803066 · WINFIELD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 37 payments from 10 companies in 2025. Trend: 2023 $251 · 2024 $338 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $314 |
| ABBVIE INC. | 4 | $102 |
| Antares Pharma, Inc. | 1 | $98 |
| Phathom Pharmaceuticals, Inc. | 4 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: CAPLYTA, XYOSTED, VRAYLAR, VOQUEZNA, FARXIGA, GVOKE HYPOPEN, XIFAXAN, Kerendia.
Industry payments across TN — which companies pay providers there.
